期刊文献+

Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms

原文传递
导出
摘要 The outbreak of COVID-19 has drawn great attention around the world.SARS-CoV-2 is a highly infectious virus with occult transmission by many mutations and a long incubation period.In particular,the emergence of asymptomatic infections has made the epidemic even more severe.Therefore,early diagnosis and timely management of suspected cases are essential measures to control the spread of the virus.Developing simple,portable,and accurate diagnostic techniques for SARS-CoV-2 is the key to epidemic prevention.The advantages of point-of-care testing technology make it play an increasingly important role in viral detection and screening.This review summarizes the point-of-care testing platforms developed by nucleic acid detection,immunological detection,and nanomaterial-based biosensors detection.Furthermore,this paper provides a prospect for designing future highly accurate,cheap,and convenient SARS-CoV-2 diagnostic technology.
出处 《Chinese Chemical Letters》 SCIE CAS CSCD 2024年第3期66-75,共10页 中国化学快报(英文版)
基金 supported by the National Key R&D Program of China(No.2021YFC2301100) the Strategic Priority Research Program of the Chinese Academy of Sciences(No.XDB30000000) the National Natural Science Foundation of China(No.61890940) the Chongqing Bayu Scholar Program(No.DP2020036) Program of Shanghai Academic Research Leaders(No.23XD1420200) Fudan University。
  • 相关文献

参考文献1

二级参考文献4

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部